Harrison SA - Search Results

1

TVB-2640 (FASN Inhibitor) for the Treatment of Nonalcoholic Steatohepatitis: FASCINATE-1, a Randomized, Placebo-Controlled Phase 2a Trial.

Loomba R, Mohseni R, Lucas KJ, Gutierrez JA, Perry RG, Trotter JF, Rahimi RS, Harrison SA, Ajmera V, Wayne JD, O'Farrell M, McCulloch W, Grimmer K, Rinella M, Wai-Sun Wong V, Ratziu V, Gores GJ, Neuschwander-Tetri BA, Kemble G. Loomba R, et al. Among authors: harrison sa. Gastroenterology. 2021 Nov;161(5):1475-1486. doi: 10.1053/j.gastro.2021.07.025. Epub 2021 Jul 23. Gastroenterology. 2021. PMID: 34310978 Free article. Clinical Trial.

2

Advances in the understanding and treatment of nonalcoholic fatty liver disease.

Harrison SA, Di Bisceglie AM. Harrison SA, et al. Drugs. 2003;63(22):2379-94. doi: 10.2165/00003495-200363220-00001. Drugs. 2003. PMID: 14609346 Review.

3

Nonalcoholic fatty liver disease and nonalcoholic steatohepatitis.

Harrison SA, Neuschwander-Tetri BA. Harrison SA, et al. Clin Liver Dis. 2004 Nov;8(4):861-79, ix. doi: 10.1016/j.cld.2004.06.008. Clin Liver Dis. 2004. PMID: 15464659 Review.

4

Effect of significant histologic steatosis or steatohepatitis on response to antiviral therapy in patients with chronic hepatitis C.

Harrison SA, Brunt EM, Qazi RA, Oliver DA, Neuschwander-Tetri BA, Di Bisceglie AM, Bacon BR. Harrison SA, et al. Clin Gastroenterol Hepatol. 2005 Jun;3(6):604-9. doi: 10.1016/s1542-3565(05)00246-6. Clin Gastroenterol Hepatol. 2005. PMID: 15952103

5

Nonalcoholic fatty liver disease presenting with an isolated elevated alkaline phosphatase.

Pantsari MW, Harrison SA. Pantsari MW, et al. Among authors: harrison sa. J Clin Gastroenterol. 2006 Aug;40(7):633-5. doi: 10.1097/00004836-200608000-00015. J Clin Gastroenterol. 2006. PMID: 16917408

6

Histopathologic variability between the right and left lobes of the liver in morbidly obese patients undergoing Roux-en-Y bypass.

Larson SP, Bowers SP, Palekar NA, Ward JA, Pulcini JP, Harrison SA. Larson SP, et al. Among authors: harrison sa. Clin Gastroenterol Hepatol. 2007 Nov;5(11):1329-32. doi: 10.1016/j.cgh.2007.06.005. Epub 2007 Aug 16. Clin Gastroenterol Hepatol. 2007. PMID: 17702661

7

Diagnosis and therapy of nonalcoholic steatohepatitis.

Torres DM, Harrison SA. Torres DM, et al. Among authors: harrison sa. Gastroenterology. 2008 May;134(6):1682-98. doi: 10.1053/j.gastro.2008.02.077. Gastroenterology. 2008. PMID: 18471547 Review.

8

Orlistat for overweight subjects with nonalcoholic steatohepatitis: A randomized, prospective trial.

Harrison SA, Fecht W, Brunt EM, Neuschwander-Tetri BA. Harrison SA, et al. Hepatology. 2009 Jan;49(1):80-6. doi: 10.1002/hep.22575. Hepatology. 2009. PMID: 19053049 Clinical Trial.

9

A pilot study using simvastatin in the treatment of nonalcoholic steatohepatitis: A randomized placebo-controlled trial.

Nelson A, Torres DM, Morgan AE, Fincke C, Harrison SA. Nelson A, et al. Among authors: harrison sa. J Clin Gastroenterol. 2009 Nov-Dec;43(10):990-4. doi: 10.1097/MCG.0b013e31819c392e. J Clin Gastroenterol. 2009. PMID: 19448566 Clinical Trial.

10

Prevalence of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis among a largely middle-aged population utilizing ultrasound and liver biopsy: a prospective study.

Williams CD, Stengel J, Asike MI, Torres DM, Shaw J, Contreras M, Landt CL, Harrison SA. Williams CD, et al. Among authors: harrison sa. Gastroenterology. 2011 Jan;140(1):124-31. doi: 10.1053/j.gastro.2010.09.038. Epub 2010 Sep 19. Gastroenterology. 2011. PMID: 20858492

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

385 results

Search Page

Filters